Arbidol Tablets (COVID-19) Market, Global Outlook and Forecast 2022-2028

February 2022 | 70 pages | ID: A2ABFB5AA989EN
Market Monitor Global

Abstracts

Arbidol Hydrochloride as known as Arbidol, is an antiviral treatment for influenza infection.

This report contains market size and forecasts of Arbidol Tablets (COVID-19) in global, including the following market information:

Global Arbidol Tablets (COVID-19) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Arbidol Tablets (COVID-19) Market Sales, 2017-2022, 2023-2028, (M Pcs)

Global top five Arbidol Tablets (COVID-19) companies in 2021 (%)

The global Arbidol Tablets (COVID-19) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

50mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Arbidol Tablets (COVID-19) include JSC Pharmstandard, Jiangsu Wuzhong Pharmaceutical, CSPC Ouyi Pharmaceutical and Simcere Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Arbidol Tablets (COVID-19) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Arbidol Tablets (COVID-19) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Arbidol Tablets (COVID-19) Market Segment Percentages, by Type, 2021 (%)

• 50mg
• 100mg

Global Arbidol Tablets (COVID-19) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Arbidol Tablets (COVID-19) Market Segment Percentages, by Application, 2021 (%)

• Anti Influenza Virus
• COVID-19

Global Arbidol Tablets (COVID-19) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Arbidol Tablets (COVID-19) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Arbidol Tablets (COVID-19) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Arbidol Tablets (COVID-19) revenues share in global market, 2021 (%)

Key companies Arbidol Tablets (COVID-19) sales in global market, 2017-2022 (Estimated), (M Pcs)

Key companies Arbidol Tablets (COVID-19) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• JSC Pharmstandard
• Jiangsu Wuzhong Pharmaceutical
• CSPC Ouyi Pharmaceutical
• Simcere Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Arbidol Tablets (COVID-19) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Arbidol Tablets (COVID-19) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ARBIDOL TABLETS (COVID-19) OVERALL MARKET SIZE

2.1 Global Arbidol Tablets (COVID-19) Market Size: 2021 VS 2028
2.2 Global Arbidol Tablets (COVID-19) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Arbidol Tablets (COVID-19) Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Arbidol Tablets (COVID-19) Players in Global Market
3.2 Top Global Arbidol Tablets (COVID-19) Companies Ranked by Revenue
3.3 Global Arbidol Tablets (COVID-19) Revenue by Companies
3.4 Global Arbidol Tablets (COVID-19) Sales by Companies
3.5 Global Arbidol Tablets (COVID-19) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Arbidol Tablets (COVID-19) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Arbidol Tablets (COVID-19) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Arbidol Tablets (COVID-19) Players in Global Market
  3.8.1 List of Global Tier 1 Arbidol Tablets (COVID-19) Companies
  3.8.2 List of Global Tier 2 and Tier 3 Arbidol Tablets (COVID-19) Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Arbidol Tablets (COVID-19) Market Size Markets, 2021 & 2028
  4.1.2 50mg
  4.1.3 100mg
4.2 By Type - Global Arbidol Tablets (COVID-19) Revenue & Forecasts
  4.2.1 By Type - Global Arbidol Tablets (COVID-19) Revenue, 2017-2022
  4.2.2 By Type - Global Arbidol Tablets (COVID-19) Revenue, 2023-2028
  4.2.3 By Type - Global Arbidol Tablets (COVID-19) Revenue Market Share, 2017-2028
4.3 By Type - Global Arbidol Tablets (COVID-19) Sales & Forecasts
  4.3.1 By Type - Global Arbidol Tablets (COVID-19) Sales, 2017-2022
  4.3.2 By Type - Global Arbidol Tablets (COVID-19) Sales, 2023-2028
  4.3.3 By Type - Global Arbidol Tablets (COVID-19) Sales Market Share, 2017-2028
4.4 By Type - Global Arbidol Tablets (COVID-19) Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Arbidol Tablets (COVID-19) Market Size, 2021 & 2028
  5.1.2 Anti Influenza Virus
  5.1.3 COVID-19
5.2 By Application - Global Arbidol Tablets (COVID-19) Revenue & Forecasts
  5.2.1 By Application - Global Arbidol Tablets (COVID-19) Revenue, 2017-2022
  5.2.2 By Application - Global Arbidol Tablets (COVID-19) Revenue, 2023-2028
  5.2.3 By Application - Global Arbidol Tablets (COVID-19) Revenue Market Share, 2017-2028
5.3 By Application - Global Arbidol Tablets (COVID-19) Sales & Forecasts
  5.3.1 By Application - Global Arbidol Tablets (COVID-19) Sales, 2017-2022
  5.3.2 By Application - Global Arbidol Tablets (COVID-19) Sales, 2023-2028
  5.3.3 By Application - Global Arbidol Tablets (COVID-19) Sales Market Share, 2017-2028
5.4 By Application - Global Arbidol Tablets (COVID-19) Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Arbidol Tablets (COVID-19) Market Size, 2021 & 2028
6.2 By Region - Global Arbidol Tablets (COVID-19) Revenue & Forecasts
  6.2.1 By Region - Global Arbidol Tablets (COVID-19) Revenue, 2017-2022
  6.2.2 By Region - Global Arbidol Tablets (COVID-19) Revenue, 2023-2028
  6.2.3 By Region - Global Arbidol Tablets (COVID-19) Revenue Market Share, 2017-2028
6.3 By Region - Global Arbidol Tablets (COVID-19) Sales & Forecasts
  6.3.1 By Region - Global Arbidol Tablets (COVID-19) Sales, 2017-2022
  6.3.2 By Region - Global Arbidol Tablets (COVID-19) Sales, 2023-2028
  6.3.3 By Region - Global Arbidol Tablets (COVID-19) Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Arbidol Tablets (COVID-19) Revenue, 2017-2028
  6.4.2 By Country - North America Arbidol Tablets (COVID-19) Sales, 2017-2028
  6.4.3 US Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.4.4 Canada Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.4.5 Mexico Arbidol Tablets (COVID-19) Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Arbidol Tablets (COVID-19) Revenue, 2017-2028
  6.5.2 By Country - Europe Arbidol Tablets (COVID-19) Sales, 2017-2028
  6.5.3 Germany Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.5.4 France Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.5.5 U.K. Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.5.6 Italy Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.5.7 Russia Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.5.8 Nordic Countries Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.5.9 Benelux Arbidol Tablets (COVID-19) Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Arbidol Tablets (COVID-19) Revenue, 2017-2028
  6.6.2 By Region - Asia Arbidol Tablets (COVID-19) Sales, 2017-2028
  6.6.3 China Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.6.4 Japan Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.6.5 South Korea Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.6.6 Southeast Asia Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.6.7 India Arbidol Tablets (COVID-19) Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Arbidol Tablets (COVID-19) Revenue, 2017-2028
  6.7.2 By Country - South America Arbidol Tablets (COVID-19) Sales, 2017-2028
  6.7.3 Brazil Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.7.4 Argentina Arbidol Tablets (COVID-19) Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Arbidol Tablets (COVID-19) Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Arbidol Tablets (COVID-19) Sales, 2017-2028
  6.8.3 Turkey Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.8.4 Israel Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.8.5 Saudi Arabia Arbidol Tablets (COVID-19) Market Size, 2017-2028
  6.8.6 UAE Arbidol Tablets (COVID-19) Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 JSC Pharmstandard
  7.1.1 JSC Pharmstandard Corporate Summary
  7.1.2 JSC Pharmstandard Business Overview
  7.1.3 JSC Pharmstandard Arbidol Tablets (COVID-19) Major Product Offerings
  7.1.4 JSC Pharmstandard Arbidol Tablets (COVID-19) Sales and Revenue in Global (2017-2022)
  7.1.5 JSC Pharmstandard Key News
7.2 Jiangsu Wuzhong Pharmaceutical
  7.2.1 Jiangsu Wuzhong Pharmaceutical Corporate Summary
  7.2.2 Jiangsu Wuzhong Pharmaceutical Business Overview
  7.2.3 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Major Product Offerings
  7.2.4 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales and Revenue in Global (2017-2022)
  7.2.5 Jiangsu Wuzhong Pharmaceutical Key News
7.3 CSPC Ouyi Pharmaceutical
  7.3.1 CSPC Ouyi Pharmaceutical Corporate Summary
  7.3.2 CSPC Ouyi Pharmaceutical Business Overview
  7.3.3 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Major Product Offerings
  7.3.4 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales and Revenue in Global (2017-2022)
  7.3.5 CSPC Ouyi Pharmaceutical Key News
7.4 Simcere Pharmaceutical
  7.4.1 Simcere Pharmaceutical Corporate Summary
  7.4.2 Simcere Pharmaceutical Business Overview
  7.4.3 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Major Product Offerings
  7.4.4 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales and Revenue in Global (2017-2022)
  7.4.5 Simcere Pharmaceutical Key News

8 GLOBAL ARBIDOL TABLETS (COVID-19) PRODUCTION CAPACITY, ANALYSIS

8.1 Global Arbidol Tablets (COVID-19) Production Capacity, 2017-2028
8.2 Arbidol Tablets (COVID-19) Production Capacity of Key Manufacturers in Global Market
8.3 Global Arbidol Tablets (COVID-19) Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ARBIDOL TABLETS (COVID-19) SUPPLY CHAIN ANALYSIS

10.1 Arbidol Tablets (COVID-19) Industry Value Chain
10.2 Arbidol Tablets (COVID-19) Upstream Market
10.3 Arbidol Tablets (COVID-19) Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Arbidol Tablets (COVID-19) Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Arbidol Tablets (COVID-19) in Global Market
Table 2. Top Arbidol Tablets (COVID-19) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Arbidol Tablets (COVID-19) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Arbidol Tablets (COVID-19) Revenue Share by Companies, 2017-2022
Table 5. Global Arbidol Tablets (COVID-19) Sales by Companies, (M Pcs), 2017-2022
Table 6. Global Arbidol Tablets (COVID-19) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Arbidol Tablets (COVID-19) Price (2017-2022) & (US$/K Pcs)
Table 8. Global Manufacturers Arbidol Tablets (COVID-19) Product Type
Table 9. List of Global Tier 1 Arbidol Tablets (COVID-19) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Arbidol Tablets (COVID-19) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Arbidol Tablets (COVID-19) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Arbidol Tablets (COVID-19) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Arbidol Tablets (COVID-19) Sales (M Pcs), 2017-2022
Table 15. By Type - Global Arbidol Tablets (COVID-19) Sales (M Pcs), 2023-2028
Table 16. By Application – Global Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Arbidol Tablets (COVID-19) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Arbidol Tablets (COVID-19) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Arbidol Tablets (COVID-19) Sales (M Pcs), 2017-2022
Table 20. By Application - Global Arbidol Tablets (COVID-19) Sales (M Pcs), 2023-2028
Table 21. By Region – Global Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Arbidol Tablets (COVID-19) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Arbidol Tablets (COVID-19) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Arbidol Tablets (COVID-19) Sales (M Pcs), 2017-2022
Table 25. By Region - Global Arbidol Tablets (COVID-19) Sales (M Pcs), 2023-2028
Table 26. By Country - North America Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Arbidol Tablets (COVID-19) Sales, (M Pcs), 2017-2022
Table 29. By Country - North America Arbidol Tablets (COVID-19) Sales, (M Pcs), 2023-2028
Table 30. By Country - Europe Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Arbidol Tablets (COVID-19) Sales, (M Pcs), 2017-2022
Table 33. By Country - Europe Arbidol Tablets (COVID-19) Sales, (M Pcs), 2023-2028
Table 34. By Region - Asia Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Arbidol Tablets (COVID-19) Sales, (M Pcs), 2017-2022
Table 37. By Region - Asia Arbidol Tablets (COVID-19) Sales, (M Pcs), 2023-2028
Table 38. By Country - South America Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Arbidol Tablets (COVID-19) Sales, (M Pcs), 2017-2022
Table 41. By Country - South America Arbidol Tablets (COVID-19) Sales, (M Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Arbidol Tablets (COVID-19) Sales, (M Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Arbidol Tablets (COVID-19) Sales, (M Pcs), 2023-2028
Table 46. JSC Pharmstandard Corporate Summary
Table 47. JSC Pharmstandard Arbidol Tablets (COVID-19) Product Offerings
Table 48. JSC Pharmstandard Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$, Mn) and Average Price (US$/K Pcs) (2017-2022)
Table 49. Jiangsu Wuzhong Pharmaceutical Corporate Summary
Table 50. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product Offerings
Table 51. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$, Mn) and Average Price (US$/K Pcs) (2017-2022)
Table 52. CSPC Ouyi Pharmaceutical Corporate Summary
Table 53. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product Offerings
Table 54. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$, Mn) and Average Price (US$/K Pcs) (2017-2022)
Table 55. Simcere Pharmaceutical Corporate Summary
Table 56. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product Offerings
Table 57. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$, Mn) and Average Price (US$/K Pcs) (2017-2022)
Table 58. Arbidol Tablets (COVID-19) Production Capacity (M Pcs) of Key Manufacturers in Global Market, 2020-2022 (M Pcs)
Table 59. Global Arbidol Tablets (COVID-19) Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Arbidol Tablets (COVID-19) Production by Region, 2017-2022 (M Pcs)
Table 61. Global Arbidol Tablets (COVID-19) Production by Region, 2023-2028 (M Pcs)
Table 62. Arbidol Tablets (COVID-19) Market Opportunities & Trends in Global Market
Table 63. Arbidol Tablets (COVID-19) Market Drivers in Global Market
Table 64. Arbidol Tablets (COVID-19) Market Restraints in Global Market
Table 65. Arbidol Tablets (COVID-19) Raw Materials
Table 66. Arbidol Tablets (COVID-19) Raw Materials Suppliers in Global Market
Table 67. Typical Arbidol Tablets (COVID-19) Downstream
Table 68. Arbidol Tablets (COVID-19) Downstream Clients in Global Market
Table 69. Arbidol Tablets (COVID-19) Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Arbidol Tablets (COVID-19) Segment by Type
Figure 2. Arbidol Tablets (COVID-19) Segment by Application
Figure 3. Global Arbidol Tablets (COVID-19) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Arbidol Tablets (COVID-19) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Arbidol Tablets (COVID-19) Revenue, 2017-2028 (US$, Mn)
Figure 7. Arbidol Tablets (COVID-19) Sales in Global Market: 2017-2028 (M Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Arbidol Tablets (COVID-19) Revenue in 2021
Figure 9. By Type - Global Arbidol Tablets (COVID-19) Sales Market Share, 2017-2028
Figure 10. By Type - Global Arbidol Tablets (COVID-19) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Arbidol Tablets (COVID-19) Price (US$/K Pcs), 2017-2028
Figure 12. By Application - Global Arbidol Tablets (COVID-19) Sales Market Share, 2017-2028
Figure 13. By Application - Global Arbidol Tablets (COVID-19) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Arbidol Tablets (COVID-19) Price (US$/K Pcs), 2017-2028
Figure 15. By Region - Global Arbidol Tablets (COVID-19) Sales Market Share, 2017-2028
Figure 16. By Region - Global Arbidol Tablets (COVID-19) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Arbidol Tablets (COVID-19) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Arbidol Tablets (COVID-19) Sales Market Share, 2017-2028
Figure 19. US Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Arbidol Tablets (COVID-19) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Arbidol Tablets (COVID-19) Sales Market Share, 2017-2028
Figure 24. Germany Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 25. France Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Arbidol Tablets (COVID-19) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Arbidol Tablets (COVID-19) Sales Market Share, 2017-2028
Figure 33. China Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 37. India Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Arbidol Tablets (COVID-19) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Arbidol Tablets (COVID-19) Sales Market Share, 2017-2028
Figure 40. Brazil Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Arbidol Tablets (COVID-19) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Arbidol Tablets (COVID-19) Sales Market Share, 2017-2028
Figure 44. Turkey Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Arbidol Tablets (COVID-19) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Arbidol Tablets (COVID-19) Production Capacity (M Pcs), 2017-2028
Figure 49. The Percentage of Production Arbidol Tablets (COVID-19) by Region, 2021 VS 2028
Figure 50. Arbidol Tablets (COVID-19) Industry Value Chain
Figure 51. Marketing Channels